Recommendations to overcome barriers to the use of artificial intelligence-driven evidence in health technology assessment.

Journal: Frontiers in public health
Published Date: Apr 26, 2023

Abstract

BACKGROUND: Artificial intelligence (AI) has attracted much attention because of its enormous potential in healthcare, but uptake has been slow. There are substantial barriers that challenge health technology assessment (HTA) professionals to use AI-generated evidence for decision-making from large real-world databases (e.g., based on claims data). As part of the European Commission-funded HTx H2020 (Next Generation Health Technology Assessment) project, we aimed to put forward recommendations to support healthcare decision-makers in integrating AI into the HTA processes. The barriers, addressed by the paper, are particularly focusing on Central and Eastern European (CEE) countries, where the implementation of HTA and access to health databases lag behind Western European countries.

Authors

  • Antal Zemplenyi
    Syreon Research Institute, Budapest, Hungary.
  • Konstantin Tachkov
    Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria.
  • Laszlo Balkanyi
    Knowledge Manager, European Centre of Disease Prevention and Control (retired).
  • Bertalan Nemeth
    Syreon Research Institute, Budapest, Hungary.
  • Zsuzsanna Ida Petykó
    Syreon Research Institute, Budapest, Hungary.
  • Guenka Petrova
    Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria.
  • Marcin Czech
    Department of Pharmacoeconomics, Institute of Mother and Child, Warsaw, Poland.
  • Dalia Dawoud
    National Institute for Health and Care Excellence, London, United Kingdom; Cairo University, Faculty of Pharmacy, Cairo, Egypt.
  • Wim Goettsch
    The National Healthcare Institute (ZIN), Diemen, The Netherlands.
  • Inaki Gutierrez Ibarluzea
    Basque Foundation for Health Innovation and Research, Barakaldo, Spain.
  • Rok Hren
    Faculty of Mathematics and Physics, University of Ljubljana, Ljubljana, Slovenia.
  • Saskia Knies
    National Health Care Institute, Diemen, Netherlands.
  • László Lorenzovici
    Syreon Research Romania, Tirgu Mures, Romania.
  • Zorana Maravic
    Digestive Cancers Europe, Brussels, Belgium.
  • Oresta Piniazhko
    HTA Department of State Expert Centre of the Ministry of Health of Ukraine, Kyiv, Ukraine.
  • Alexandra Savova
    Department of Organization and Economics of Pharmacy, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria.
  • Manoela Manova
    Department of Organization and Economics of Pharmacy, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria.
  • Tomas Tesar
    Department of Organisation and Management of Pharmacy, Faculty of Pharmacy, Comenius University in Bratislava, Bratislava, Slovakia.
  • Spela Zerovnik
    Ministry of Health, Ljubljana, Slovenia.
  • Zoltan Kalo
    Syreon Research Institute, Budapest, Hungary.

Keywords

External Resources

Popular Topics
Recent Journals